The American Hospital Association just rushed off a wish list of things it wants the 119th Congress to do before the 120th convenes, ushering in Democrat control of both chambers at noon on Jan. 3.
The U.S. District Court ruled that Supreme Court precedent has confirmed that the authority to regulate disputes related to the discount drug program rests with the Department of Health and Human Services. As such, Tampa General’s case cannot move forward.
From 2019 to 2022, Ali Naserdean, 32, and a coconspirator defrauded Medicare, Medicaid and Blue Cross Blue Shield by forging prescriptions for controlled substances, which were then sold on the black market.
If 1,265 children benefit from repeated head CT scans while suffering no harms from the cumulative exposure to ionizing radiation, is the one child out of that cohort who gets a radiation-associated brain tumor—that is, child No. 1,266—to be considered acceptable collateral damage?
Before enrolling in Medicare during their senior years, many American adults fluctuate between having and not having health insurance. A new study sheds light on how the population’s coverage status might be optimized over the lifetimes of existing generations.
In a proposed rule, the agency has outlined new protocols for revoking provider and medical equipment supplier enrollments in federal health programs should they be suspected of engaging in fraud.
For its analysis the Health Management Academy gathered data from news reports and announcements, finding that some of the incidents that delay surgeries or divert ambulances aren’t reported to the federal government.
An Oklahoma pharmaceutical company is accused of failing to comply with federal regulations. The FDA is prepared to remove its statin from the market altogether.